Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A Single-arm, multicentre, phase 2 trial - Balar, A V; Galsky, M D; Rosenberg, J E (Lancet (London, England), 2017)
et al.